Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO).
- Disclosed ownership: 7.4%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 7.4% ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 7.2% | 5,405,269 | 0 | 5,405,269 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 7.2% | 5,405,269 | 0 | 5,405,269 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 7.2% | 5,405,269 | 0 | 5,405,269 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0% | 6,600 | 0 | 6,600 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 0.1% | 92,950 | 0 | 92,950 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 0.1% | 92,950 | 0 | 92,950 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 7.4% | 5,498,219 | 0 | 5,498,219 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |